Literature DB >> 8781962

Determination of anti-AGE antibodies in human serum.

S Baydanoff1, E Konova, N Ivanova.   

Abstract

The aim of this study was to develop an immunoenzyme method for the determination of anti-AGE antibodies in human serum. Human aortic elastin glycated in vitro (AGE-elastin) was used as an antigen, expressing AGE-epitopes, common to all glycated proteins. Polyclonal serum from guinea-pig against AGE-Hemocyanin was obtained according to Nakayama et al. [(1989) Biochem Biophys Res Commun 162: 740-45] and its specificity was tested via direct and competitive ELISA. Sera of 20 type 1 diabetic patients and 20 healthy subjects were tested using the method described. Seventeen patients had elevated levels of competing factors that may be anti-AGE antibodies, compared with the healthy group. The method could be used for investigation of different clinical groups of type 1 diabetic patients. Such a study would help in understanding the pathogenic role of autoantibodies against advanced glycation end products of proteins for the development of long-term diabetic complications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781962     DOI: 10.1007/bf00731464

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  14 in total

1.  The chemistry of connective tissues. 2. Soluble proteins derived from partial hydrolysis of elastin.

Authors:  S M PARTRIDGE; H F DAVIS; G S ADAIR
Journal:  Biochem J       Date:  1955-09       Impact factor: 3.857

2.  Production and characterization of antibodies to advanced glycation products on proteins.

Authors:  H Nakayama; S Taneda; S Kuwajima; S Aoki; Y Kuroda; K Misawa; S Nakagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-07-31       Impact factor: 3.575

Review 3.  Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Authors:  H Vlassara; R Bucala; L Striker
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

Review 4.  Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications.

Authors:  H Vlassara; M Brownlee; A Cerami
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

5.  Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications.

Authors:  V Vishwanath; K E Frank; C A Elmets; P J Dauchot; V M Monnier
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

6.  Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Diabetes       Date:  1985-09       Impact factor: 9.461

7.  Nonenzymatic glucosylation and glucose-dependent cross-linking of protein.

Authors:  A S Eble; S R Thorpe; J W Baynes
Journal:  J Biol Chem       Date:  1983-08-10       Impact factor: 5.157

8.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

Authors:  R Bucala; K J Tracey; A Cerami
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.

Authors:  M Brownlee; S Pongor; A Cerami
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

10.  Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.

Authors:  E Y Skolnik; Z Yang; Z Makita; S Radoff; M Kirstein; H Vlassara
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  2 in total

1.  Elevated IgG and IgM Autoantibodies to Advanced Glycation End Products of Vascular Elastin in Hypertensive Patients with Type 2 Diabetes: Relevance to Disease Initiation and Progression.

Authors:  Krasimir Kostov; Alexander Blazhev
Journal:  Pathophysiology       Date:  2022-08-01

2.  Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice.

Authors:  Musthika Wida Mashitah; Nurona Azizah; Nur Samsu; Muhammad Rasjad Indra; Muhammad Bilal; Meti Verdian Yunisa; Amildya Dwi Arisanti
Journal:  Diabetes Metab Syndr Obes       Date:  2015-08-04       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.